Turnover and distribution of cathepsin G in the rat

References

• Ohlsson K, Olsson I, Spitznagel J K. Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe-Seyler's Z Physiol Chem 1977; 358: 361–6
   PubMedGoogle Scholar
• Ohlsson K, Akesson U. α1-antichymotrypsin interaction with cationic proteins from granulocytes. Clin Chim Acta 1976; 73: 285–91
   PubMed Web of Science ®Google Scholar
• Thompson R C., Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl Acad Sci 1986; 83: 66–926
   Web of Science ®Google Scholar
• Björk P, Axelsson L, Ohlsson K. Release of dog polymorphonuclear leukocyte cathepsin G, normally and in endotoxin and pancreatitic shock. Biol Chem Hoppe-Seyler 1991; 372: 419–26
   PubMed Web of Science ®Google Scholar
• Björk P, Ohlsson K. Purification and N-terminal amino-acid sequence analysis of rat polymorphonuclear leukocyte cathepsin G. Biol Chem Hoppe-Seyler 1990; 371: 595–601
   PubMed Web of Science ®Google Scholar
• Bangalore N, Travis J, Onunka V C., Pohl J, Schafer W M. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem 1990; 265: 135–848
   Web of Science ®Google Scholar
• Selak M A., Smith J B. Cathepsin G binding to human platelets. Evidence for a specific receptor. Biochem J 1990; 266: 55–62
   PubMed Web of Science ®Google Scholar
• Kurdowska A, Travis J. Acute phase protein stimulation by arantichymotrypsin-cathepsin G complexes. G complexes. J Biol Chem 1990; 265: 210–236
   Web of Science ®Google Scholar
• Björk P, Ohlsson K. The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse. Mediators of Inflammation 1992; 1: 27–31
   PubMedGoogle Scholar
• Gauthier F, Mouray H. Rat α2 acute-phase macro-globulin isolation and physicochemical properties. Biochem J 1976; 159: 661–5
   PubMed Web of Science ®Google Scholar
• Gauthier F, Ohlsson K. Isolation and some properties of a new enzyme-binding protein in rat plasma. Hoppe-Seyler's Z Physiol Chem 1978; 359: 98–792
   Google Scholar
• Greenwood F C., Hunter W M., Glover J S. The preparation of1311-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–23
   PubMed Web of Science ®Google Scholar
• Laurell C B. Electroimmuno assay. Scand J Clin Lab Invest 1972; 29(Suppl 124)21–37
   Web of Science ®Google Scholar
• Sternberger L A., Hardy P H., JR, Cuculis J J., Meyer H G. The unlabelled antibody enzyme method of immunochemistry, preparation and properties of soluble antigen-antibody complex (horseradish per-oxidase-antihorseradhish peroxidase) and its use in identification of Spirochetes. J Histochem Cyto-chem 1970; 18: 315–33
   Google Scholar
• Ohlsson K, Olsson I. The extracellular release of granulocyte collagenase and elastase during phago-cytosis and inflammatory processes. Scand J Hea-matol 1970; 19: 154–52
   Google Scholar
• Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988; 84(Suppl 6A)37–42
   PubMed Web of Science ®Google Scholar
• Pizzo S V., Mast A E., Feldman S R., Salvesen G. in vivo catabolism of a-antichymotrypsin is mediated by the Serpin receptor that binds a]-proteinase inhibitor, antitrombin III and heparin cofactor II. Biochim Biophys Acta 1988; 967: 158–62
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Laurell C B. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med 1976; 51: 87–92
   PubMedGoogle Scholar
• Fuchs H E., Shifman M A., Pizzo S V. In vivo catabolism of ci -proteinase inhibitor-trypsin, antithrom-bin III-thrombin and a2-macroglobulin-methylamine. Biochim Biophys Acta 1982; 716: 151–7
   PubMed Web of Science ®Google Scholar
• Koj A, Magielska-Zero D, Kurdowska A, Bereta J. Proteinase inhibitors as acute phase reactants: Regulation of synthesis and turnover. Adv Exp Med Biol 1988; 240: 171–81
   PubMedGoogle Scholar
• Lonberg-Holm K, Reed D L., Roberts R C., Hebert R R., Hillman M C., Kutney R M. Three high molecular weight protease inhibitors of rat plasma. J Biol Chem 1987; 262: 438–45
   PubMed Web of Science ®Google Scholar
• Falkenberg C, Grubb A, Akerstrom B. Isolation of rat serum a!-microglobulin. J Biol Chem 1990; 265: 16150–7
   PubMed Web of Science ®Google Scholar
• Kuehn L, Rutschmann M, Dahlman B, Reinauer H. Proteinase inhibitors of rat serum. Purification and partial characterization of three functionally distinct trypsin inhibitors. Biochem J 1984; 218: 953–9
   PubMed Web of Science ®Google Scholar
• Hill R E., Shaw P H., Boyd P A., Baumann H, Hastie N D. Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions. Nature 1984; 311: 175–7
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Tsujino Y, Saito A, Sinohara H. Concentrations of murinoglobulin and a-macro-glubulin in the mouse serum: variations with age, sex, strain and experimental inflammation. Biochem Int 1985; 10: 463–9
   PubMedGoogle Scholar
• Pirie-Shepherd S R., Miller H RP, Ryle A. Differential inhibition of rat mast cell proteinase I and II by members of the a-1-proteinase inhibitor family of serine proteinase inhibitors. J Biol Chem 1991; 266: 17314–9
   PubMed Web of Science ®Google Scholar
• Crocker J, Jenkins R, Burnett D. Immunohisto-chemical localization of cathepsin G in human tissues. Am J Surg Pathol 1985; 9: 338–43
   PubMed Web of Science ®Google Scholar
• Nelson R B., Siman Clipsin R. a chymptrypsin-like protease in rat brain which is irreversibly inhibited by Q-1-antichymotrypsin. J Biol Chem 1990; 265: 2836–43
   Web of Science ®Google Scholar